3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
9
Phase 3
4
Phase 2/3
2
Phase NA
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Esophageal Squamous Cell Carcinoma
1
Interventions
Cisplatin
9
pembrolizumab
7
Irinotecan
7
Radiotherapy
6
Fluorouracil
6
Docetaxel
5
spartalizumab
4
Oxaliplatin
4
130-nm albumin-bound paclitaxel
4
Nivolumab
3
Carboplatin
3
toripalimab
2
tislelizumab
2
elgemtumab
2
durvalumab
2
Radiation
2
Paclitaxel
2
Leucovorin
2
Gemcitabine
2
Drug Therapy
2
vandetanib
1
tremelimumab
1
ribociclib
1
palbociclib
1
obinutuzumab
1
nedaplatin
1
nazartinib
1
naptumomab estafenatox
1
liposomal doxorubicin
1
dalpiciclib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Esophageal Squamous Cell Carcinoma
×
Esophagectomy
×
Clear all
NCT07317609
2026-01-05
Endosurgery-02
Shanghai Zhongshan Hospital
Phase 1
Recruiting
60 enrolled